Beta-2-agonists are some of the major class of bronchodilators used for asthma management.According to published data, allelic variants of the arginase ARG1 and ARG2 genes are associated with a risk ofasthma development, spirometry measures and efficacy of bronchodilator therapy. Here, ARG1 is linked to asthma.